Summer Sale Pomalidomide-propargyl - Final Sale [rb8XdfG7]

Pomalidomide-Propargyl: A Targeted Protein Degradation Building Block

Welcome to Pomalidomide-Propargyl, a cutting-edge degrader building block designed for targeted protein degradation. This versatile compound contains an E3 ligase ligand with a linker and a function group, enabling straightforward conjugation to target protein ligands through chemical reactions. With its exceptional purity of >=95% (HPLC), Pomalidomide-Propargyl is the ideal choice for researchers seeking precision and reliability in their experiments. Its unique properties make it a powerful tool in the field of drug discovery and development.

• High Purity: Ensures accurate and consistent results in your experiments.
• Targeted Protein Degradation: Enables precise manipulation of protein levels, crucial for understanding biological processes and developing new therapeutic approaches.

Product Specifications and Technical Details

Pomalidomide-Propargyl is a highly pure compound with a molecular formula of C16H13N3O4 and a molecular weight of 311.297. It features a SMILES notation of O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C(NCC#C)C=CC=C12, providing a detailed chemical description. This compound is suitable for shipping at room temperature but should be stored refrigerated to maintain its stability. With a shelf life of 12 months after delivery, Pomalidomide-Propargyl offers long-term reliability for your research needs.

• Molecular Formula: C16H13N3O4
• Molecular Weight: 311.297
• Shipping Conditions: Room temperature
• Storage Conditions: Refrigerated
• Shelf Life: 12 months after delivery

Applications and Benefits of Pomalidomide-Propargyl

Pomalidomide-Propargyl is a versatile tool with numerous applications in research and development. Its ability to conjugate to target protein ligands makes it invaluable for studying protein-protein interactions, identifying novel drug targets, and developing potential therapeutic agents. This compound is particularly useful in the fields of oncology, immunology, and neurodegenerative diseases, where understanding protein degradation pathways is critical.

• Drug Discovery and Development: Accelerates the identification of new therapeutic targets and the development of potential drugs.
• Research in Oncology, Immunology, and Neurodegenerative Diseases: Facilitates the study of protein degradation pathways, leading to a deeper understanding of disease mechanisms.